GlassScriptPhysician profile
Ke Xie
NPI 1427373661
$6,197.58
in general payments reported to CMS, 2019-2025
13 companies · $4,149 in 2025
The $4,149 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $775 · 2020: $37.46 · 2021: $40.09 · 2022: $370 · 2023: $454 · 2024: $373 · 2025: $4,149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,809 · Travel and Lodging: $1,696 · Consulting Fee: $1,470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,808.98 |
| Travel and Lodging | $1,695.52 |
| Consulting Fee | $1,470.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $2,154.16 | 2019-2025 | Velys, Monovisc, Orthovisc |
| Medical Device Business Services, INC. | $1,595.31 | 2025 | Attune |
| Zimmer Biomet Holdings, INC. | $1,187.01 | 2019-2025 | Persona, G7, Avitus Bone Harvester |
| Supreme Orthopedic Systems, LLC | $695.66 | 2019-2023 | |
| Stryker Corporation | $276.38 | 2024-2025 | Mako, Triathlon |
| Abbott Laboratories | $125.58 | 2023 | Proclaim |
| Sanara Medtech INC. | $41.58 | 2024 | Celleraterx |
| Fidia Pharma USA INC. | $29.20 | 2023-2024 | Hymovis, Triluron |
| Ethicon US, LLC | $20.44 | 2025 | Stratafix, Ethicon |
| Convatec INC. | $20.25 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $19.23 | 2023 | Zilretta, Iovera, Exparel |
| Biowound Solutions, INC. | $18.75 | 2025 | Bio-Connekt |
| Heraeus Medical, LLC. | $14.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ke Xie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.